TrialThe Journal of allergy and clinical immunology2023

Open-label study of the efficacy, safety, and durability of peanut sublingual immunotherapy in peanut-allergic children.

Edwin H Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.